Our Research Publications

Updated November 2023

Title Authors Year Journal Link to Article Intended Audience Purpose
ResearchUnit: Red cell irradiation - time for a change? Serrano K 2014 Blood.ca website View Other Other
ResearchUnit: Reducing bleeding after cardiac surgery: fibrinogen concentrate vs cryoprecipitate Karkouti K 2020 Blood.ca website View Health care providers Clinical research
ResearchUnit: Research into TRALI therapies gene therapy results that are a TAD interesting! Semple J 2014 Blood.ca website View Other Other
ResearchUnit: Risk of HIV did not change with expanding eligibility criteria for gay, bisexual and other men who have sex with men Walsh G 2022 Blood.ca website View Regulators MSM research
ResearchUnit: Searching for safer red blood cell bags for pediatric recipients Serrano K, Acker J 2016 Blood.ca website View Other Other
ResearchUnit: Sex-mismatched red blood cell transfusions and mortality Zeller M 2019 Blood.ca website View Health care providers Clinical research
ResearchUnit: Sexual behaviour-based screening questions: Understanding and mitigating donor discomfort Woo H 2022 Blood.ca website View Blood operators MSM research
ResearchUnit: Should patients receive HLA-selected platelets? Shehata N 2013 Blood.ca website View Other Other
ResearchUnit: Single site solution: engineering novel antibodies for the treatment of ITP Lazarus A 2015 Blood.ca website View Other Other
ResearchUnit: Supporting evidence to change regulations regarding the storage of cryosupernatant plasma. Sheffield W 2013 Blood.ca website View Other Other
ResearchUnit: Treating bleeding during cardiac surgery: Is prothrombin complex concentrate a substitute for plasma? Kron A 2021 Blood.ca website View Health care providers Clinical research
ResearchUnit: Treatment and detection of vaccine-induced thrombotic thrombocytopenia (VITT) Abe T 2021 Blood.ca website View Health care providers Clinical research
ResearchUnit: United we stand, divided we fall: using monoclonal antibody combinations to improve drug effectiveness Lazarus A 2016 Blood.ca website View Other Other
ResearchUnit: Using Immunocamouflage to Fool the Immune System Scott MD 2015 Blood.ca website View Other Other
ResearchUnit: Using immunocamouflage to increase transplantation safety Scott M 2017 Blood.ca website View Other Other
ResearchUnit: What if the shelf life of red blood cells was less than 42 days? Blake J 2013 Blood.ca website View Other Other
ResearchUnit: What is the risk of a transfusion-transmitted infection? O'Brien S 2013 Blood.ca website View Other Other
ResearchUnit: What is the utility of selecting platelets by cross-matching? Shehata N 2013 Blood.ca website View Other Other
ResearchUnit: Where is the blood going? Understanding red blood cell utilization to inform policies Zeller M, Heddle N, Devine D 2017 Blood.ca website View Other Other
ResearchUnit: Whole blood: longer holding times before leukoreduction may be a safe to explore option Chen ZY 2022 Blood.ca website View Regulators New or improved product or process
Residual risk of bacterial contamination of platelets: six years of experience with sterility testing Ramirez-Arcos S, DiFranco C, McIntyre T, Goldman M 2017 Transfusion View Researchers New or improved product or process
Residual Risk of HIV, HCV and HBV in Canada O'Brien SF, Yi Q-L, Fan W, Scalia V, Goldman M, Fearon MA 2017 Transfus Apher Sci View Health care providers Clinical research
Resistance of SARS-CoV-2 beta and gamma variants to plasma collected from Canadian blood donors during the spring of 2020 Drews SJ, Abe KT, Hu Q, Samson R, Gingras A-C, Colwill K, Rathod B, Wang J, Fazel-Zarandi M, Yi Q-L, Robinson A, Wood H, Tuite A, Fisman D, Evans DH, Lin Y-CJ, O'Brien SF 2022 Transfusion View Researchers Clinical research
Resolving variable maternal D typing using serology and genotyping in selected prenatal patients Clarke G, Hannon J, Berardi P, Barr G, Cote J, Fallis R, Alport T, Lane D, Petraszko T, Ochoa G, Goldman M 2016 Transfusion View Health care providers New or improved product or process
Response to ‘Adverse cardiac outcomes in patients with chronic myeloid leukaemia treated with tyrosine kinase inhibitors’ Leong D, Hillis C, Aghel N, Pond G, Seow H 2021 Heart View Researchers Clinical research
Restrictive or liberal red-cell transfusion for cardiac surgery Mazer CD, Whitlock RP, Fergusson DA, Hall J, Belley-Cote E, Connolly K, Khanykin B, Gregory AJ, de Medicis E, McGuinness S, Royse A, Carrier FM, Young PJ, Villar JC, Grocott HP, Seeberger MD, Fremes S, Lellouche F, Syed S, Byrne K, Bagshaw SM, Hwang NC, Mehta C, Painter TW, Royse C, Verma S, Hare GMT, Cohen A, Thorpe KE, Juni P, Shehata N 2017 N Engl J Med View Health care providers Clinical research
Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support Estcourt LJ, Malouf R, Trivella M, Fergusson DA, Hopewell S, Murphy MF 2017 Cochrane Database Syst Rev View Health care providers Clinical research
Retention of hemostatic and immunological properties of frozen plasma and COVID-19 convalescent apheresis fresh-frozen plasma produced and freeze-dried in Canada Sheffield WP, Bhakta V, Howell A, Jenkins C, Serrano K, Johnson N, Lin Y-CJ, Colwill K, Rathod B, Greenberg B, Gingras A-C, Evans DH, Flaumenhaft E, Beckett A, Drews SJ, Devine DV 2022 Transfusion View Researchers Basic research
Retention of thrombin inhibitory activity by recombinant serpins expressed as integral membrane proteins tethered to the surface of mammalian cells Gierczak RF, Sutherland JS, Bhakta V, Toltl LJ, Liaw PC, Sheffield WP 2011 J Thromb Haemost View Researchers Basic research
Rethinking platelet transfusion practices Devine DV 2021 Blood View Health care providers New or improved product or process
Revealing the diversity of extracellular vesicles using high-dimensional flow cytometry analyses Marcoux G, Duchez A-C, Cloutier N, Provost P, Nigrovic PA, Boilard E 2016 Sci Rep View Researchers Basic research
Reversible hemostatic properties of sulfabetaine/quaternary ammonium modified hyperbranched polyglycerol Wen J, Weinhart M, Lai B, Kizhakkedathu J, Brooks DE 2016 Biomaterials View Researchers Basic research
Revisiting study design and methodology for pathogen reduced platelet transfusions: a round table discussion Heddle NM, Cardoso M, van der Meer PF 2020 Transfusion View Researchers Clinical research
Rh System: Anti-Cw Meunier D, Peng S, Clarke G 2019 Blood.ca website View Health care providers Benchmarking and standard setting
Rh System: Anti-V Meunier D, Peng S, Clarke G 2019 Blood.ca website View Health care providers Benchmarking and standard setting
RhD Specific Antibodies Are Not Detectable in HLA-DRB1(*)1501 Mice Challenged with Human RhD Positive Erythrocytes Bernardo L, Denomme GA, Shah K, Lazarus AH 2014 Adv Hematol View Researchers Basic research
RhoA/ROCK signaling contributes to sex differences in the activation of human platelets Schubert P, Coupland D, Nombalais M, Walsh G, Devine DV 2016 Thromb Res View Researchers Basic research
Riboflavin and ultraviolet illumination affects selected platelet mRNA transcript amounts differently Klein-Bosgoed C, Schubert P, Devine DV 2016 Transfusion View Researchers Basic research
Riboflavin and ultraviolet light treatment of platelets triggers p38MAPK signaling: inhibition significantly improves in vitro platelet quality after pathogen reduction treatment Schubert P, Coupland D, Culibrk B, Goodrich RP, Devine DV 2013 Transfusion View Researchers Basic research
Riboflavin and ultraviolet light treatment potentiates vasodilator-stimulated phosphoprotein Ser-239 phosphorylation in platelet concentrates during storage Schubert P, Culibrk B, Coupland D, Scammell K, Gyongyossy-Issa M, Devine DV 2012 Transfusion View Researchers Basic research
rIgG1 Fc Hexamer Inhibits Antibody-Mediated Autoimmune Disease via Effects on Complement and Fc?Rs Spirig R, Campbell IK, Koernig S, Chen C-G, Lewis BJB, Butcher R, Muir I, Taylor S, Chia J, Leong D, Simmonds J, Scotney P, Schmidt P, Fabri L, Hofmann A, Jordi M, Spycher MO, Cattepoel S, Brasseit J, Panousis C, Rowe T, Branch DR, Baz Morelli A, Kaesermann F, Zuercher AW 2018 J Immunol View Researchers Basic research
rIgG1 Fc hexamer inhibits antibody-mediated autoimmune disease via effects on complement and FcgammaRs Spirig R, Campbell IK, Koernig S, Chen CG, Lewis BJB, Butcher R, Muir I, Taylor S, Chia J, Leong D, Simmonds J, Scotney P, Schmidt P, Fabri L, Hofmann A, Jordi M, Spycher MO, Cattepoel S, Brasseit J, Panousis C, Rowe T, Branch DR, Baz Morelli A, Kasermann F, Zuercher AW 2018 J Immunol View Researchers Basic research
Rights and interests in human bodies and biological materials Toews M, Caulfield T, Nelson E, Ogbogu U, Hartell D 2015 Canadian National Transplant Research Program Fast Policy Facts: Human Bodies and Biological Materials View Other Other
Risk analysis of transfusion of cryoprecipitate without consideration of ABO group Hadjesfandiari N, Levin E, Serrano K, Yi Q-L, Devine DV 2021 Transfusion View Health care providers Benchmarking and standard setting
Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis Lauzier F, Arnold DM, Rabbat C, Heels-Ansdell D, Zarychanski R, Dodek P, Ashley BJ, Albert M, Khwaja K, Ostermann M, Skrobik Y, Fowler R, McIntyre L, Nates JL, Karachi T, Lopes RD, Zytaruk N, Finfer S, Crowther M, Cook D 2013 Intensive Care Med View Health care providers Clinical research
Risk factors for bleeding in people living with hemophilia A and B treated with regular prophylaxis: A systematic review of the literature Germini F, Noronha N, Abraham Philip B, Olasupo O, Pete D, Navarro T, Keepanasseril A, Matino D, de Wit K, Parpia S, Iorio A 2022 J Thromb Haemost View Researchers Clinical research
Risk factors for neonatal thrombosis: A retrospective study conducted in a single Canadian intensive care unit Bhatia K, Solanki S, Paes B, Chan AKC, Bhatt MD 2022 Pediatr Blood Cancer View Researchers Clinical research
Risk infection to spare bleeding? The quandary of splenectomy for immune thrombocytopenia Zeller M, Arnold DM 2015 Am J Hematol View Health care providers Clinical research
Risk of acute kidney injury in patients randomized to a restrictive versus liberal approach to red blood cell transfusion in cardiac surgery: a substudy protocol of the transfusion requirements in cardiac surgery III noninferiority trial Garg AX, Shehata N, McGuinness S, Whitlock R, Fergusson D, Wald R, Parikh C, Bagshaw SM, Khanykin B, Gregory A, Syed S, Hare GMT, Cuerden MS, Thorpe KE, Hall J, Verma S, Roshanov PS, Sontrop JM, Mazer CD 2018 Can J Kidney Health Dis View Researchers Clinical research
Risk of exposure to blood products during pregnancy: guidance for Zika and other donor deferral policies Murphy MS, Shehata N, Colas JA, Chassé M, Fergusson DA, O'Brien SF, Goldman M, Tinmouth A, Forster AJ, Wilson K 2017 Transfusion View Health care providers Clinical research